RAPP

Rapport Therapeutics is a drug development company working on treatments for brain and nerve disorders. The company is testing experimental medicines designed to treat epilepsy, nerve pain, bipolar disorder, migraines, and hearing problems. These drugs are still in clinical trials, meaning they have not yet been approved by regulators or sold to patients.